Avaii Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$588K Buy
15,751
+2,704
+21% +$125K 0.17% 82
2026
Q2
$625K Sell
13,047
-123,301
-90% -$5.3M 0.18% 72
2026
Q1
$5.01M Buy
136,348
+122,911
+915% +$5.82M 1.75% 19
2025
Q4
$684K Buy
13,437
+9,098
+210% +$465K 0.25% 51
2025
Q3
$241K Buy
+4,339
New +$254K 0.09% 131

Other funds holding NVO

Avaii Wealth Management's NVO Position: Q3 2026 in Review

Avaii Wealth Management increased its Novo Nordisk (NVO) stake by 21% in Q3 2026, buying an estimated $125K and bringing the position to 15,751 shares worth $588K. The position accounts for 0.17% of the portfolio, ranked #82.

Avaii Wealth Management first reported a position in NVO in Q3 2025 and has held it in 5 quarters since. The position peaked at $5.01M in Q1 2026. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Avaii Wealth Management held 15,751 shares of Novo Nordisk worth $588K as of Q3 2026.
  • Avaii Wealth Management bought 2,704 Novo Nordisk shares in Q3 2026, an estimated $125K.
  • Novo Nordisk made up 0.17% of Avaii Wealth Management's portfolio in Q3 2026, its #82 holding.
  • Avaii Wealth Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 5 quarters since.
  • Avaii Wealth Management's Novo Nordisk position peaked at $5.01M in Q1 2026.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Avaii Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.